Procode AI vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
$4M seed led by Story Ventures in 2026; acquired The Auctus Group to execute a build-then-buy RCM strategy for surgical billing.
About
Procode AI is an AI-powered revenue cycle management company focused specifically on surgical billing — one of the highest-complexity, highest-value slices of the RCM market. The company pairs AI automation with operational capacity acquired via M&A rather than building a pure-software GTM.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.